2023 Inhibition in the CNS Gordon Research Conference and Gordon Research Seminar

项目摘要 下一次戈登研究会议（GRC）在中枢神经系统的抑制将召开 Les Diablerets，瑞士，2023年7月16日至21日。这一国际研究会议每隔 自2005年以来，作为GRC系列会议的一部分，与往年一样， 15-16，2023，由戈登研究研讨会（GRS），这为初级提供了一个独特的氛围 科学家，包括博士后和研究生，讨论和交流新的发现和想法， 为GRC做准备。中枢神经系统中的抑制主要由神经递质驱动 GABA已被证明是大脑功能的基础，当干扰导致 功能障碍GRC将提供一个重要的论坛，让该领域的领导者和正在崛起的年轻科学家 新的明星将有机会交流新的概念和方法，以推动该领域的发展。的 本次会议的总体科学目标是探索健康大脑抑制领域的主要主题， 以更好地理解改变的抑制在神经和神经精神疾病中的作用。实现 为了实现这一目标，会议将追求以下具体目标： 在健康和疾病中抑制的基础研究问题，以增加多样性和促进 网络合作，并提供培训，网络和研究生的职业发展 和博士后会议将通过选择34位世界级演讲者和9场讨论来实现这些目标 领导者，其中许多是来自13个不同国家的初级小组领导者（20名美国科学家，17名 妇女）。越来越多的证据表明GABA缺陷与神经发育和神经系统疾病有关。 因此，GRC/GRS会议对健康影响的强调将最大限度地讨论 并寻求新的抑制回路治疗靶点来治疗破坏性脑损伤 紊乱

Project Summary The next Gordon Research Conference (GRC) on inhibition in the Central Nervous System will be convened at Les Diablerets, Switzerland, on July 16-21, 2023. This international research conference has been held every two years since 2005 as part of the GRC conference series. As in previous years, it will be preceded on July 15-16, 2023, by the Gordon Research Seminar (GRS), which provides a unique atmosphere for junior scientists, including postdocs and graduate students, to discuss and exchange novel findings and ideas in preparation for the GRC. Inhibition in the Central Nervous System is mainly driven by the neurotransmitter GABA, which has been proven to be fundamental for brain function and, when the perturbed result in dysfunction. The GRC will provide a major forum where leaders in the field and junior scientists who are rising new stars will have the opportunity to exchange novel concepts and approaches to advance the field. The general scientific goal of this meeting is to explore leading topics in the field of inhibition in healthy brains and to better understand the role of altered inhibition in neurological and neuropsychiatric disorders. To achieve this goal, the meeting will pursue the following specific aims: to select speakers that will discuss cutting-edge fundamental research questions in inhibition within health and disease, to increase diversity and promote network collaborations, and provide training, networking and career promotion of graduate students and postdocs. The meeting will attain these aims by selecting 34 world-class speakers and 9 discussion leaders, many of whom are junior group leaders from 13 different countries (20 US-based scientists, 17 women). There is growing evidence linking GABA deficits to neurodevelopmental and neurological disorders. As such, the GRC/GRS meetings' emphasis on health impact will maximize discussion of fundamental questions in this field and seek novel therapeutic targets of inhibitory circuitries to treat devastating brain disorders.